Johna Herrmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johna herrmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johna Herrmann Today - Breaking & Trending Today

Novavax, Inc. (NASDAQ:NVAX) Receives $204.86 Consensus Target Price from Analysts

Novavax, Inc. (NASDAQ:NVAX – Get Rating) has been given an average rating of “Buy” by the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year target price among analysts […] ....

Johna Herrmann , Thomson Reuter , Principal Financial Group Inc , Hightower Advisors , Comerica Bank , Jpmorgan Chase Co , Mackenzie Financial Corp , Cantor Fitzgerald , Novavax Inc , Get Rating , Marketbeat Ratings , Financial Group , Financial Corp , Tower Advisors , Nasdaq Nvax ,

Avantax Advisory Services Inc. Acquires 604 Shares of Novavax, Inc. (NASDAQ:NVAX)

Avantax Advisory Services Inc. grew its holdings in Novavax, Inc. (NASDAQ:NVAX – Get Rating) by 13.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,127 shares of the biopharmaceutical company’s stock after purchasing an additional 604 shares during the quarter. Avantax Advisory Services Inc.’s […] ....

Johna Herrmann , Selective Wealth Management Inc , Securities Exchange Commission , Financial Group Inc , Exchange Commission , Jpmorgan Chase Co , Jefferies Financial Group , Cantor Fitzgerald , Moors Cabot Inc , Avantax Advisory Services Inc , Continuum Advisory , Novavax Inc , Avantax Advisory Services , Get Rating , Advisory Services , Wealth Management , Group Inc , Financial Group , Nasdaq Nvax , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Novavax, Inc. (NASDAQ:NVAX) Receives $204.86 Consensus Target Price from Brokerages

Shares of Novavax, Inc. (NASDAQ:NVAX – Get Rating) have received a consensus rating of “Buy” from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target […] ....

Johna Herrmann , Gregorym Glenn , Securities Exchange Commission , Lord Abbett , Connor Clark Lunn Investment Management Ltd , Ikarian Capital , Jpmorgan Chase Co , Cantor Fitzgerald , Novavax Company Profile Get Rating , Novavax Inc , Get Rating , Marketbeat Ratings , Exchange Commission , World Investors , Street Corp , Connor Clark , Lunn Investment Management , Company Profile , Middle East , Nasdaq Nvax ,